Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1978 1
1981 8
1982 9
1983 19
1984 31
1985 28
1986 49
1987 59
1988 70
1989 100
1990 115
1991 100
1992 102
1993 136
1994 107
1995 106
1996 120
1997 117
1998 115
1999 107
2000 109
2001 110
2002 107
2003 115
2004 115
2005 109
2006 116
2007 112
2008 91
2009 86
2010 104
2011 96
2012 87
2013 70
2014 77
2015 69
2016 56
2017 61
2018 51
2019 56
2020 53
2021 49
2022 42
2023 57
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

3,315 results

Results by year

Filters applied: . Clear all
Page 1
Drug treatment for panic disorder with or without agoraphobia: systematic review and network meta-analysis of randomised controlled trials.
Chawla N, Anothaisintawee T, Charoenrungrueangchai K, Thaipisuttikul P, McKay GJ, Attia J, Thakkinstian A. Chawla N, et al. BMJ. 2022 Jan 19;376:e066084. doi: 10.1136/bmj-2021-066084. BMJ. 2022. PMID: 35045991 Free PMC article.
OBJECTIVE: To identify drug classes and individual selective serotonin reuptake inhibitors (SSRIs) with high rates of remission and low risk of adverse events in the treatment of panic disorder with or without agoraphobia. ...ELIGIBILITY CRITERIA FOR STUDY SE …
OBJECTIVE: To identify drug classes and individual selective serotonin reuptake inhibitors (SSRIs) with high rates of remission and l …
Role of Benzodiazepines in Anxiety Disorders.
Balon R, Starcevic V. Balon R, et al. Adv Exp Med Biol. 2020;1191:367-388. doi: 10.1007/978-981-32-9705-0_20. Adv Exp Med Biol. 2020. PMID: 32002938 Review.
This chapter reviews the role of benzodiazepines (BZs) in the treatment of anxiety disorders, specifically panic disorder with or without agoraphobia, generalized anxiety disorder, and social anxiety disorder (social phobia). ...
This chapter reviews the role of benzodiazepines (BZs) in the treatment of anxiety disorders, specifically panic disorder with …
Panic disorder.
Weinstein RS. Weinstein RS. Am Fam Physician. 1995 Nov 15;52(7):2055-63, 2067-8. Am Fam Physician. 1995. PMID: 7484706 Review.
Panic disorder is a chronic illness that affects at least 3 percent of the population. Panic disorder is associated with significant morbidity and an increased risk of suicide. ...
Panic disorder is a chronic illness that affects at least 3 percent of the population. Panic disorder is associa …
Panic disorder.
Rapaport MH, Barrett C. Rapaport MH, et al. Curr Psychiatry Rep. 2001 Aug;3(4):295-301. doi: 10.1007/s11920-001-0022-1. Curr Psychiatry Rep. 2001. PMID: 11470036 Review.
In this article, the authors review the most recent advances in the pharmacotherapy, psychotherapy, and combined therapy for panic disorder. The authors focus on peer-reviewed data and on pragmatic clinical approaches that may help patients suffering f …
In this article, the authors review the most recent advances in the pharmacotherapy, psychotherapy, and combined therapy for …
Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.
Gelder MG. Gelder MG. J Clin Psychopharmacol. 1998 Dec;18(6 Suppl 2):2S-5S. doi: 10.1097/00004714-199812001-00002. J Clin Psychopharmacol. 1998. PMID: 9872706 Review.
Cognitive behavior therapy (CBT) has been combined with pharmacotherapy in the treatment of panic disorder in three ways: (1) to treat agoraphobic symptoms in the condition of panic with agoraphobia; (2) to reduce withdrawal effects during dr …
Cognitive behavior therapy (CBT) has been combined with pharmacotherapy in the treatment of panic disorder in th …
Treatment-resistant panic disorder.
Rosenbaum JF. Rosenbaum JF. J Clin Psychiatry. 1997;58 Suppl 2:61-4; discussion 65. J Clin Psychiatry. 1997. PMID: 9078997 Review.
Although effective pharmacologic and psychosocial treatments are available for panic disorder, many patients continue to experience residual anxiety symptoms, recurrent panic attacks, or continuing impairment and distress. ...
Although effective pharmacologic and psychosocial treatments are available for panic disorder, many patients continue to exper …
Relapse prevention in panic disorder with pharmacotherapy: where are we now?
Caldirola D, Alciati A, Daccò S, Micieli W, Perna G. Caldirola D, et al. Expert Opin Pharmacother. 2020 Oct;21(14):1699-1711. doi: 10.1080/14656566.2020.1779220. Epub 2020 Jun 16. Expert Opin Pharmacother. 2020. PMID: 32543949
Introduction: A substantial number of patients with PD experience relapse after the discontinuation of effective pharmacotherapy, leading to detrimental effects on the individuals and considerable societal costs. This suggests the need to optimize pharmacotherapy to …
Introduction: A substantial number of patients with PD experience relapse after the discontinuation of effective pharmacotherapy, lea …
Treatment-resistant panic disorder.
Bandelow B, Rüther E. Bandelow B, et al. CNS Spectr. 2004 Oct;9(10):725-39. doi: 10.1017/s1092852900022379. CNS Spectr. 2004. PMID: 15448584 Review.
A substantial number of patients with panic disorder and agoraphobia may remain symptomatic after standard treatment (including selective serotonin reuptake inhibitors, tricyclic antidepressants, benzodiazepines, or irreversible monamine oxidase inhibitors). In this …
A substantial number of patients with panic disorder and agoraphobia may remain symptomatic after standard treatment (includin …
Initial white matter connectivity differences between remitters and non-remitters of patients with panic disorder after 6 months of pharmacotherapy.
Song CR, Kang NO, Bang M, Park CI, Choi TK, Lee SH. Song CR, et al. Neurosci Lett. 2021 Apr 23;751:135826. doi: 10.1016/j.neulet.2021.135826. Epub 2021 Mar 13. Neurosci Lett. 2021. PMID: 33727131
Panic disorder (PD) is a harmful mental condition that causes relapsed and persistent impairment. ...After six months, there were 17 remission patients with PD and 81 non-remission patients. The Panic Disorder Severity Scale, Albany Panic and Ph …
Panic disorder (PD) is a harmful mental condition that causes relapsed and persistent impairment. ...After six months, there w …
Panic: course, complications and treatment of panic disorder.
Pollack MH, Marzol PC. Pollack MH, et al. J Psychopharmacol. 2000;14(2 Suppl 1):S25-30. doi: 10.1177/02698811000142S104. J Psychopharmacol. 2000. PMID: 10888028 Review.
Panic disorder is a chronic condition typically associated with significant distress and disability. ...A number of pharmacological agents and cognitive-behavioural treatments have been shown to be effective in the treatment of panic disorder, with the …
Panic disorder is a chronic condition typically associated with significant distress and disability. ...A number of pharmacolo …
3,315 results